Device typeIsocitrate dehydrogenase 2 (IDH2) gene mutation IVD, kit, nucleic acid technique (NAT): A collection of reagents and other associated materials intended to be used to diagnose, monitor or predict the isocitrate dehydrogenase 2 (IDH2) gene mutation status of a clinical specimen, using a nucleic acid technique (NAT). Mutations of the IDH2 gene are commonly found in cases of glioma and acute myeloid leukaemia (AML).
FDA categorySomatic gene mutation detection system
Device ID00884999047044
Catalog number08N82-090
AvailabilityPrescription
Single useYes
MRI safetyLabeling does not contain MRI Safety Information